A comparison of responses to intravitreal bevacizumab, ranibizumab, or aflibercept injections for neovascular age-related macular degeneration
Crossref DOI link: https://doi.org/10.1007/s10792-016-0391-4
Published Online: 2016-11-08
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Park, Dae Hyun
Sun, Hae Jung
Lee, Sung Jin
License valid from 2016-11-08